Protein trafficking defects in inherited kidney diseases
- 27 August 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 29 (suppl 4) , iv33-iv44
Abstract
The nephron, the basic structural and functional unit of the kidney, is lined by different, highly differentiated polarized epithelial cells. Their concerted action modifies the composition of the glomerular ultrafiltrate through reabsorption and secretion of essential solutes to finally produce urine. The highly specialized properties of the different epithelial cell types of the nephron are remarkable and rely on the regulated delivery of specific proteins to their final subcellular localization. Hence, mutations affecting sorting of individual proteins or inactivating the epithelial trafficking machinery have severe functional consequences causing disease. The presence of mutations leading to protein trafficking defect is indeed a mechanism of pathogenesis seen in an increasing number of disorders, including about one-third of monogenic diseases affecting the kidney. In this review, we focus on representative diseases to discuss different molecular mechanisms that primarily lead to defective protein transport, such as endoplasmic reticulum retention, mistargeting, defective endocytosis or degradation, eventually resulting in epithelial cell and kidney dysfunction. For each disease, we discuss the type of reported mutations, their molecular and cellular consequences and possible strategies for therapeutic intervention. Particular emphasis is given to new and prospective therapies aimed at rescuing the trafficking defect at the basis of these conformational diseases.Keywords
This publication has 87 references indexed in Scilit:
- Nephrogenic Diabetes Insipidus: Essential Insights into the Molecular Background and Potential Therapies for TreatmentEndocrine Reviews, 2013
- New strategies for the treatment of lysosomal storage diseases (Review)International Journal of Molecular Medicine, 2012
- Congenital nephrogenic diabetes insipidus: the current state of affairsPediatric Nephrology, 2012
- Genetic kidney diseasesThe Lancet, 2010
- Short-chain ubiquitination mediates the regulated endocytosis of the aquaporin-2 water channelProceedings of the National Academy of Sciences, 2006
- Rescue of Vasopressin V2 Receptor Mutants by Chemical Chaperones: Specificity and MechanismMolecular Biology of the Cell, 2006
- Disease‐causing V2 Vasopressin Receptors are Retained in Different Compartments of the Early Secretory PathwayTraffic, 2004
- Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidusProceedings of the National Academy of Sciences, 2000
- Mutations in the V2 vasopressin receptor gene are associated with X–linked nephrogenic diabetes insipidusNature Genetics, 1992
- Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidusNature, 1992